Thyroid diseases and weight gain: A less explored relationship
M3 Global Newsdesk Jun 11, 2022
There is a complex connection between thyroid disease and weight. This article explains the scientific link between weight and thyroid cancer as well as weight and autoimmune disease. It also explains the post-treatment effects on weight.
Key takeaways
- The relationship between thyroid disease and weight is complicated.
- Weight gain in euthyroid individuals, and particularly in lean persons who become obese, raises the risk of thyroid cancer.
- After treatment for hypo- or hyperthyroidism, weight tends to return to baseline levels evident before the disease.
Basal metabolic rate (BMR) used to be an important test for analyzing patients’ thyroid status. Patients with underactive thyroid glands have low BMRs, and vice versa.
Due to the complexity of measuring BMR, this practice fell out of favour. Various other mechanisms likely play a role in the relationship between thyroid disease, body weight, and metabolism (the amount of oxygen used by the body during a period of time).
Autoimmune disease and weight
A rise in obesity and autoimmune disorders has been noted in recent decades. Studies have pointed to a relationship between thyroid autoimmunity and obesity. The proposed relationship could be bidirectional, with some data suggesting that thyroid autoimmunity is the cause of hyperlipidemia and abdominal obesity, while others indicate it’s a result of obesity.
According to the authors of an article published in Endocrine research, the adipocytokine leptin could play a pivotal role in the development of thyroid autoimmunity in obese individuals.
The authors wrote:
“It is argued that obesity can impair thyroid function in different aspects such as activation of the hypothalamic-pituitary-thyroid axis and increased deiodinase activity. Changes in thyroid function tests in obese individuals are probably a result of obesity rather than its cause since weight loss normalizes thyroid function tests.”
Weight and thyroid cancer
In a study published in Scientific Reports, Korean researchers mined a large population-based cohort to assess the relationship between obesity and thyroid cancer. The investigators excluded participants who were receiving treatment for hypothyroidism or hyperthyroidism.
They found that higher BMI and larger waist circumference correlated with increased risk of thyroid cancers in both men and women, with higher BMI and larger waist circumference showing an even more pronounced association in men.
Investigators also found that weight gain in lean individuals increased the risk of developing thyroid cancer, whereas weight loss in obese individuals decreased that risk.
Explanations tying obesity and thyroid cancer could include inflammation, impaired immune response, oxidative stress, higher thyroid-stimulating hormone (TSH) levels, hyperinsulinemia, adipokines, and higher aromatase activity. Chronic low-grade inflammation could also result in the formation of reactive oxygen species, lower tumour suppression, and a higher cell-cycle rate.
Furthermore, higher TSH levels could trigger the growth of thyroid cells with higher levels of mutation, leading to the proliferation of thyroid cancer.
Weight changes after treatment
Patients who receive treatment for hyperthyroidism can expect to gain back any weight they originally lost due to the condition, according to the American Thyroid Association. Even if they never lost weight, they may gain some upon starting treatment because they’ve grown accustomed to eating more calories while hyperthyroid.
On the other hand, hypothyroid patients tend to lose some weight during treatment. Because most weight gained secondary to hypothyroidism is due to the accumulation of salt and water, a patient’s expected weight loss is usually 10% or less of their body weight. The usual weight loss seen in hypothyroidism is relatively less than the weight gain seen with this condition. It is rare to see massive weight gain in hypothyroid conditions.
Treatment for hypothyroidism results in a return to the baseline weight maintained before the condition began. Once hypothyroidism is treated, the ability to gain or lose weight is the same as in any euthyroid individual.
Clinicians should keep in mind that if weight gain is the only symptom indicative of hypothyroidism, then it’s less likely that weight gain is due only to an underactive thyroid. Thyroid hormones have been used to promote weight loss.
Although excessively increasing thyroid levels can lead to more weight loss than dieting alone, the practice carries risks such as loss of muscle protein and bone, and heart problems. And once the administration of excess thyroid hormone is stopped, any lost weight is usually regained.
What does this mean for you?
The relationship between weight and thyroid status is complex, but certain expectations can be shared with your patients. A good reason to promote weight loss in obesity cases is to decrease the risk of thyroid cancer. Hypothyroid patients can expect to lose some weight after treatment, but it’s relatively less than the weight gained after treatment. With both hypo- and hyperthyroid conditions, the treatment restores body weight to baseline levels, before the abnormality began. If patients then gain or lose weight, they will do so in the same patterns as persons without any thyroid impairment.
Disclaimer: This story is contributed by Naveed Saleh and is a part of our Global Content Initiative, where we feature selected stories from our Global network which we believe would be most useful and informative to our doctor members.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries